Cassone, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.284
AS - Asia 4.417
EU - Europa 3.862
SA - Sud America 732
AF - Africa 108
OC - Oceania 77
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.485
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.087
SG - Singapore 1.360
CN - Cina 1.341
IT - Italia 1.049
GB - Regno Unito 933
HK - Hong Kong 590
BR - Brasile 549
SE - Svezia 463
DE - Germania 293
VN - Vietnam 280
RU - Federazione Russa 215
FI - Finlandia 193
JP - Giappone 143
TR - Turchia 141
FR - Francia 136
ID - Indonesia 128
KR - Corea 121
UA - Ucraina 108
CA - Canada 104
IE - Irlanda 104
IN - India 93
AR - Argentina 78
BG - Bulgaria 70
AU - Australia 69
MX - Messico 66
NL - Olanda 59
LT - Lituania 44
PL - Polonia 43
PK - Pakistan 41
TN - Tunisia 40
MY - Malesia 26
ZA - Sudafrica 26
AT - Austria 24
BD - Bangladesh 24
IQ - Iraq 24
EC - Ecuador 23
ES - Italia 23
PE - Perù 21
CL - Cile 19
CO - Colombia 17
HU - Ungheria 17
PT - Portogallo 17
JO - Giordania 14
VE - Venezuela 13
BE - Belgio 12
BZ - Belize 12
IR - Iran 12
PH - Filippine 11
KE - Kenya 10
EG - Egitto 9
MA - Marocco 9
RO - Romania 9
SA - Arabia Saudita 9
CH - Svizzera 8
NZ - Nuova Zelanda 8
RS - Serbia 8
UZ - Uzbekistan 8
DK - Danimarca 6
DZ - Algeria 6
NP - Nepal 6
TH - Thailandia 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
IL - Israele 5
PY - Paraguay 5
EU - Europa 4
LU - Lussemburgo 4
LV - Lettonia 4
OM - Oman 4
DO - Repubblica Dominicana 3
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
MU - Mauritius 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
IS - Islanda 2
KH - Cambogia 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
JM - Giamaica 1
KW - Kuwait 1
Totale 17.477
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.226
Singapore 880
Fairfield 853
Ashburn 770
Hong Kong 569
Chandler 507
Hefei 464
Southend 451
Woodbridge 341
Houston 290
Seattle 275
Nyköping 264
Wilmington 263
London 262
Cambridge 240
Ann Arbor 215
Beijing 180
Los Angeles 156
Helsinki 148
Jacksonville 142
New York 136
Modena 120
Dearborn 110
Dallas 108
Jakarta 101
The Dalles 101
Chicago 100
San Diego 97
Seoul 96
Ho Chi Minh City 93
Shanghai 88
Milan 86
Moscow 75
Dublin 72
Sofia 70
Princeton 68
Redwood City 64
Hanoi 63
Buffalo 61
Munich 55
São Paulo 54
Tokyo 53
Rome 50
Council Bluffs 49
Perth 47
Izmir 41
Bologna 39
Bremen 39
Salt Lake City 37
Eugene 36
San Jose 36
Columbus 31
Elk Grove Village 29
Frankfurt am Main 27
Kent 27
Nuremberg 27
Manchester 26
Orem 26
Falls Church 25
Brooklyn 24
Montreal 24
Warsaw 24
Mexico City 23
San Francisco 23
Ankara 21
Bari 21
Boardman 21
Redondo Beach 21
Toronto 21
Atlanta 20
Chennai 19
Turku 19
Boston 18
Dong Ket 18
Rio de Janeiro 17
Istanbul 16
Santiago 16
Buenos Aires 15
Catania 15
Guangzhou 14
Mumbai 14
Ottawa 14
Stockholm 14
Tampa 14
Brasília 13
Haiphong 13
Poplar 13
Reggio Nell'emilia 13
Belize City 12
Da Nang 12
Denver 12
Las Vegas 12
Parma 12
Phoenix 12
Porto Alegre 12
Amman 11
Brussels 11
Johannesburg 11
Lappeenranta 11
Norwalk 11
Totale 11.616
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.237
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 363
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 359
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 309
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 306
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 300
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 286
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 281
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 280
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 277
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 276
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 264
Caratteristiche cliniche e nuovi orizzonti diagnostico-terapeutici delle vasculiti dei grandi vasi e della interstiziopatia polmonare secondaria ad artrite reumatoide. 259
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 258
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 243
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 241
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 236
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 235
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 233
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 229
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 228
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 221
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 215
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 215
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 214
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 213
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 213
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 203
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 201
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 199
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 198
Nailfold videocapillaroscopy in antisynthetase syndrome 197
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 195
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 191
Severe alopecia complicating systemic sclerosis 190
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 184
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 184
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 182
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 177
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 173
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 171
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 167
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 162
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 159
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 158
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 158
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 157
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 156
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 155
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab 154
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients 153
The rediscovery of hydroxychloroquine in allergic diseases in the covid-19 era 153
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 148
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 144
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 142
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 142
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 140
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 135
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 134
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 133
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis 130
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 129
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 124
Fibrosing interstitial lung disease in primary Sjogren syndrome 124
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 122
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 119
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 119
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 119
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 119
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 118
CLINICAL OUTCOMES OF TREATMENT WITH GOLIMUMAB IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE SETTINGS. DATA FROM ITALIAN REGISTER GISEA 118
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 116
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 115
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 114
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 113
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 111
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 110
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 109
Rheumatoid arthritis related interstitial lung disease 109
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 107
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 107
FRI0212 THE ROLE OF AGE ON THE CLINICAL PRESENTATION AND RELAPSE RATES IN A LARGE COHORT OF 720 PATIENTS WITH GIANT CELL ARTERITIS 104
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 100
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 98
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 97
Reactive Granulomatous Dermatitis during Anti-TNF Therapy: A Case Report and Review of the Literature 96
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 94
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 93
Granuloma annulare as a possible new adverse effect of topiramate 92
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 88
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 86
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 86
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium" 83
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 81
NAILFOLD CAPILLAROSCOPY IN ANTISYNTHETASE SYNDROME (NASCAR): RESULTS OF A MULTICENTER, INTERNATIONAL STUDY OF THE AMERICAN AND EUROPEAN NETWORK OF ANTISYNTHETASE SYNDROME (AENEAS) 80
Reply to the comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Bilgin et al 77
HARNESSING THE POWER OF RADIOMICS TO PREDICT SURVIVAL IN PATIENTS WITH RA-ILD 73
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 71
EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY 69
Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysis 62
Totale 17.568
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.234 0 0 0 0 0 135 225 197 184 211 143 139
2021/20221.747 144 106 111 99 91 137 81 91 209 173 321 184
2022/20231.874 211 178 145 138 211 215 87 207 230 47 115 90
2023/20241.590 68 89 75 232 219 125 129 254 47 54 123 175
2024/20254.678 143 69 108 319 961 737 396 205 489 174 451 626
2025/20264.009 533 368 640 920 975 573 0 0 0 0 0 0
Totale 17.722